Mirum Pharmaceuticals Eigendom
Wie zijn de grootste aandeelhouders en hebben insiders gekocht of verkocht?
Recente transacties met voorkennis
Datum | Waarde | Naam | Entiteit | Rol | Aandelen | Maximale prijs |
---|---|---|---|---|---|---|
18 Sep 24 | BuyUS$4,301 | Frazier Life Sciences Management, LP | Company | 115 | US$37.40 | |
06 Sep 24 | BuyUS$9,563 | Frazier Life Sciences Management, LP | Company | 230 | US$41.58 | |
27 Mar 24 | BuyUS$49,600 | Eric Bjerkholt | Individual | 2,000 | US$24.80 | |
25 Mar 24 | SellUS$111,017 | Peter Radovich | Individual | 4,303 | US$25.80 | |
18 Mar 24 | BuyUS$51,600 | Eric Bjerkholt | Individual | 2,000 | US$25.80 | |
02 Feb 24 | SellUS$157,491 | Christopher Peetz | Individual | 6,013 | US$26.19 | |
02 Feb 24 | SellUS$31,797 | Pamela Vig | Individual | 1,214 | US$26.19 | |
02 Feb 24 | SellUS$46,883 | Peter Radovich | Individual | 1,790 | US$26.19 | |
02 Feb 24 | SellUS$22,184 | Lara Longpre | Individual | 847 | US$26.19 | |
08 Jan 24 | SellUS$146,033 | Christopher Peetz | Individual | 5,209 | US$28.03 | |
08 Jan 24 | SellUS$39,472 | Pamela Vig | Individual | 1,408 | US$28.03 | |
08 Jan 24 | SellUS$39,473 | Peter Radovich | Individual | 1,408 | US$28.03 | |
08 Jan 24 | SellUS$28,568 | Lara Longpre | Individual | 1,019 | US$28.04 |
Volume handel met voorkennis
Insider-aankopen: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Opsplitsing eigendom
Type eigenaar | Aantal Aandelen | Eigendomspercentage |
---|---|---|
Individuele insiders | 832.246 | 1,48% |
Hedgefondsen | 4.370.024 | 7,77% |
VC/PE-bedrijven | 6.495.507 | 11,5% |
Instellingen | 44.566.442 | 79,2% |
Verwatering van aandelen: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.3%.
Topaandeelhouders
Eigendom | Naam | Aandelen | Huidige waarde | Verandering % | Portefeuille % | |
---|---|---|---|---|---|---|
6.495.507 | US$262.4m | 0% | 10,47% | |||
4.988.747 | US$201.5m | 80,3% | 0,08% | |||
4.370.024 | US$176.5m | 0% | 4,34% | |||
3.614.820 | US$146.0m | 9,53% | 2,3% | |||
3.368.157 | US$136.1m | 4,02% | geen gegevens | |||
2.446.733 | US$98.8m | 10,6% | geen gegevens | |||
1.772.038 | US$71.6m | -4,55% | 2,05% | |||
1.585.624 | US$64.1m | 13,9% | 0,06% | |||
1.500.000 | US$60.6m | 0% | 0,04% | |||
1.496.217 | US$60.4m | -47% | geen gegevens | |||
1.287.107 | US$52.0m | 8,42% | 4,3% | |||
1.235.121 | US$49.9m | -46,1% | 1,97% | |||
1.199.220 | US$48.4m | -24,9% | geen gegevens | |||
938.881 | US$37.9m | 0% | 0,01% | |||
907.180 | US$36.7m | 30,1% | geen gegevens | |||
875.113 | US$35.4m | -8,45% | 0,02% | |||
794.125 | US$32.1m | -11,6% | 1,79% | |||
741.049 | US$29.9m | 18,6% | 0,11% | |||
731.104 | US$29.5m | -36% | 1,13% | |||
726.645 | US$29.4m | 9,01% | 0,01% | |||
703.398 | US$28.4m | -26,6% | 4,25% | |||
699.933 | US$28.3m | 166% | 0,02% | |||
677.939 | US$27.4m | 8,08% | 0,03% | |||
614.905 | US$24.8m | -15,5% | geen gegevens | |||
529.030 | US$21.4m | 53,7% | geen gegevens |